retatrutide trial news 🚨 Big dropped today — and here's why it actually matters. Yes, the “reta rats” have been talking about this molecule for years. But today's TRIUMPH-1 Phase 3 results aren't Lilly's Retatrutide Scores Triple Trial

Common criteria include failed trials of oral diabetes medications, documented BMI thresholds (often 30+), and baseline metabolic or cardiometabolic risk factors

A review in Gut Microbes described it as a "butyrate-producing human gut symbiont" with documented benefits for intestinal barrier integrity, immune modulation, and metabolic signaling

We need to break this one down because it lands in the middle of one of the most high-profile regulatory and legal battles in recent FDA history: the fight over compounded GLP-1 drugs

Blood glucose levels were monitored at 10, 20, 30, 60, and 90 min post-injection

Consumers allege in lawsuits that these companies sold compounded or mislabeled semaglutide products without providing informed consent about the dangers